26 participants
Rituximab Combined With Chidamide and Lenalidomide for r/r AITL
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-03-24
- Start Date:
- 2020-03-13
- Completion:
- 2022-03-31
Conditions
- Angioimmunoblastic T-cell Lymphoma
- Chemotherapy Effect
- Chemotherapeutic Toxicity
Interventions
- DRUG
No Results Yet